Back

Who benefits from angiography-derived FFR-guided revascularization? Defining the beneficial population and its key features

29 August 2026 (14:50 - 15:10)
Organised by: Logo
Congress Presentation Part of: Young Investigator Award Session in Interventional Cardiology Intracoronary Flow and Pressure Measurements ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Doctor Hao-Yu Wang

Fuwai Hospital, CAMS and PUMC, Beijing (China)

2 More presentations in this session

Presentation thumbnail
Complete revascularization across PRECISE-HBR bleeding risk strata in older patients with myocardial infarction and multivessel coronary artery disease: a FIRE trial subanalysis
Doctor A. Sarti (Ferrara, IT)
Abstract
Presentation thumbnail
Artificial intelligence–driven three-vessel OCT quantification identifies the vulnerable patient and predicts 1-year outcomes in acute coronary syndromes
Doctor H. Ramteke (Chimur, IN)
Abstract

Access the full session

Session thumbnail
Young Investigator Award Session in Interventional Cardiology

The Event

Event poster

ESC Congress 2026

29 August 2026 14:50 CET
You may be interested in
thumbnail
Congress Presentation
Quantitative flow ratio in predicting residual angina: is it better than the eye?
1 September 2025
thumbnail
Congress Presentation
The FRAME-AMI trial - FFR vs. Angiography-guided PCI in AMI with multivessel disease
28 August 2022
thumbnail
Congress Presentation
The clinical outcome of fractional flow reserve based coronary revascularization strategy of the patients on hemodialysis
27 August 2021
thumbnail
Congress Presentation
Prognostic implications of CT-derived FFR in proximal vs. distal coronary segments
30 August 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources